EQS Group-News: COSMO Pharmaceuticals N.V. / Key word(s): Miscellaneous DETECT study shows AI assistance using GI Genius(TM) reduces missed polyp rate by nearly 50% on initial colonoscopy 19.11.2021 / ...
In a fast-paced world where stress and distractions overwhelm our daily lives, the quest for optimal mental performance has never been more critical. Enter the Genius Wave, a revolutionary audio track ...
Dublin, Ireland--(Newsfile Corp. - September 2, 2024) - Cosmo Intelligent Medical Devices (Cosmo IMD), a division of Cosmo Pharmaceuticals N.V. (SIX: COPN) (FSE: C43) (“Cosmo”), the developer and ...
A 2,000-patient U.K. study has been set up to generate real-world evidence of the value of using AI technology to detect bowel polyps (adenomas) during colonoscopy procedures. The aim is to show ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results